Human Health Division (HHD) Products

Product List by Generic Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Ospemifene

Composition

Osmina Tablet: Each film coated tablet contains Ospemifene INN 60 mg.

Indication

Osmina is an estrogen agonist/antagonist indicated for the treatment of moderate to severe dyspareunia & vaginal dryness, a symptom of vulvar and vaginal atrophy, due to menopause. 

Dosage & Administration

Osmina is an estrogen agonist/antagonist which has agonistic effects on the endometrium. Use of Osmina should be for the shortest duration consistent with treatment goals and risks for the individual women. One tablet should be taken orally once daily with food or as directed by the physician.

Olmesartan + Amlodipine

Composition
OlmepinTM 20/5 Tablet:Each film coated tablet contains Olmesartan Medoxomil USP 20 mg & Amlodipine Besilate BP equivalent to Amlodipine 5 mg.
Olmepin TM 40/5 Tablet:Each film coated tablet contains Olmesartan Medoxomil USP 40 mg & Amlodipine Besilate BP equivalent to Amlodipine 5 mg.

Indication
OlmepinTM is indicated for the treatment of hypertension, alone or with other antihypertensive agents. OlmepinTM may also be used as initial therapy in patients 
who are likely to need multiple antihypertensive agents to achieve their blood pressure goals.

Dose & Administration
Initial Therapy: The usual starting dose of Olmesartan Medoxomil/Amlodipine Besilate is 20/5 mg one tablet once daily. The dosage can be increased after 1 to 2 weeks of 
therapy to a maximum dose of 40/10 mg once daily as needed to control blood pressure. This combination may be taken with or without food. This combination may 
be administered with other antihypertensive agents. Initial therapy with this combination products is not recommended in patients >75 
years old or with hepatic impairment. Replacement therapy: Olmesartan Medoxomil/Amlodipine Besilate may be substituted for its individually titrated components. When substituting for individual components, 
the dose of one or both of the components can be increased if blood pressure control has not been satisfactory.
Add-on Therapy: Olmesartan Medoxomil/Amlodipine Besilate may be used to provide additional blood pressure lowering for patients not adequately controlled with 
Amlodipine (or another dihydropyridine Calcium Channel Blocker) alone or with Olmesartan Medoxomil (or another angiotensin II receptor blocker) alone Or as 
directed by the physician

Ozenoxacin

Composition:
Zenocin Cream: Each gram cream contains Ozenoxacin INN 10 mg.

Indication:
Zenocin Cream is indicated for the topical treatment of impetigo due to Staphylococcus aureus or Streptococcus pyogenes in adult and paediatric patients 2 months of age and older.

Dose & Administration:
Apply a thin layer of Zenocin cream topically to the affected area twice daily for five days or as directed by the physicians.

Omeprazole

Composition
Ometac™ 20: Each capsule contains Omeprazole BP 20 mg.


Indications:
It is used for the treatment of oesophageal reflux disease, duodenal and benign gastric ulcer including those complicating NSAID therapy, Zollinger Ellison syndrome.

Dose & Administration:
Reflux Oesophagitis : The usual dose is 20 mg once daily for 4 weeks. For those patients not fully healed after the initial course ,a further 4-8 weeks treatment may require. Or as directed by the physician.

Olopatadine

Composition:
AllelocDS Sterile Eye Drops: Each ml contains Olopatadine
Hydrochloride USP equivalent to Olopatadine 2 mg.
Indications:
Allergic conjunctivitis.
Dosage and administration:
AllelocDS: Instill one drop in the affected eye (s) once daily
or as directed by the physician.